Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based review.

Heelan K, Knowles S, Walsh S, Shear NH.

J Eur Acad Dermatol Venereol. 2014 Apr;28(4):520-2. doi: 10.1111/jdv.12217. Epub 2013 Jul 24. Review. No abstract available.

PMID:
23888984
2.

Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.

Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E.

J Am Acad Dermatol. 2011 Sep;65(3):552-8. doi: 10.1016/j.jaad.2010.07.032.

PMID:
21641080
3.

Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab.

Heelan K, Hassan S, Bannon G, Knowles S, Walsh S, Shear NH, Mittmann N.

J Cutan Med Surg. 2015 May-Jun;19(3):274-82. doi: 10.2310/7750.2014.14092. Epub 2015 Mar 13.

PMID:
25775641
4.

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis.

Lehane PB, Lacey S, Hessey EW, Jahreis A.

Ann Rheum Dis. 2014 Oct;73(10):1906-8. doi: 10.1136/annrheumdis-2014-205474. Epub 2014 Jul 29. No abstract available.

5.

First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.

Cho YT, Lee FY, Chu CY, Wang LF.

Acta Derm Venereol. 2014 Jul;94(4):472-3. doi: 10.2340/00015555-1746. No abstract available.

6.

Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.

Craythorne EE, Mufti G, DuVivier AW.

J Am Acad Dermatol. 2011 Nov;65(5):1064-5. doi: 10.1016/j.jaad.2010.06.033. No abstract available.

PMID:
22000877
7.

Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.

Cianchini G, Lupi F, Masini C, Corona R, Puddu P, De Pità O.

J Am Acad Dermatol. 2012 Oct;67(4):617-22. doi: 10.1016/j.jaad.2011.11.007. Epub 2012 Jan 13.

PMID:
22243765
8.

Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.

Matsukura S, Knowles SR, Walsh S, Shear NH.

Arch Dermatol. 2012 Jun;148(6):734-9. doi: 10.1001/archdermatol.2011.3320. Erratum in: Arch Dermatol. 2012 Sep 1;148(9):1012. Dosage error in article text. Arch Dermatol. 2012 Aug;148(8):970. Dosage error in article text.

PMID:
22351790
9.

Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.

Kamphausen I, Schulze F, Schmidt E, Zillikens D, Kunz M.

Eur J Dermatol. 2012 Nov-Dec;22(6):786-7. doi: 10.1684/ejd.2012.1843. No abstract available.

PMID:
23114083
10.

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients.

Leshem YA, Hodak E, David M, Anhalt GJ, Mimouni D.

J Am Acad Dermatol. 2013 Mar;68(3):404-11. doi: 10.1016/j.jaad.2012.08.010. Epub 2012 Oct 6.

PMID:
23044076
11.

Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial.

Gregoriou S, Giatrakou S, Theodoropoulos K, Katoulis A, Loumou P, Toumbis-Ioannou E, Papadavid E, Avgerinou G, Stavrianeas N, Rigopoulos D.

Dermatology. 2014;228(2):158-65. doi: 10.1159/000357031. Epub 2014 Feb 15.

PMID:
24557145
12.

Efficacy and safety of rituximab treatment in Indian pemphigus patients.

Kanwar AJ, Tsuruta D, Vinay K, Koga H, Ishii N, Dainichi T, Hashimoto T.

J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e17-23. doi: 10.1111/j.1468-3083.2011.04391.x. Epub 2011 Dec 17.

PMID:
22176540
13.

Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.

Aoi J, Makino K, Sakai K, Masuguchi S, Fukushima S, Jinnin M, Inoue Y, Koga H, Hashimoto T, Ihn H.

J Dermatol. 2013 Apr;40(4):285-6. doi: 10.1111/1346-8138.12095. Epub 2013 Feb 11. No abstract available.

PMID:
23398274
14.

Childhood pemphigus vulgaris successfully treated with rituximab.

Kanwar AJ, Sawatkar GU, Vinay K, Hashimoto T.

Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):632-4. doi: 10.4103/0378-6323.100587.

15.

Off-label use of rituximab in dermatology: pemphigus treatment.

Bomm L, Fracaroli TS, Sodré JL, Bressan A, Gripp AC.

An Bras Dermatol. 2013 Jul-Aug;88(4):676-8. doi: 10.1590/abd1806-4841.20131905.

16.

Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases.

Kasperkiewicz M, Eming R, Behzad M, Hunzelmann N, Meurer M, Schulze-Koops H, von Wussow P, Hertl M, Zillikens D, Freivogel K, Dörner T, Schmidt E.

J Dtsch Dermatol Ges. 2012 Oct;10(10):727-32. doi: 10.1111/j.1610-0387.2012.07931.x. Epub 2012 May 11.

PMID:
22577946
17.

Successful use of rituximab in the treatment of childhood and juvenile pemphigus.

Vinay K, Kanwar AJ, Sawatkar GU, Dogra S, Ishii N, Hashimoto T.

J Am Acad Dermatol. 2014 Oct;71(4):669-75. doi: 10.1016/j.jaad.2014.05.071. Epub 2014 Jul 9.

PMID:
25022850
18.

Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.

Chiba T, Tsuji G, Mitoma H, Takahara M, Moroi Y, Miyamoto T, Furue M.

Haemophilia. 2013 Mar;19(2):e98-9. doi: 10.1111/hae.12087. No abstract available.

PMID:
23419110
19.

Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.

Reguiai Z, Tabary T, Maizières M, Bernard P.

J Am Acad Dermatol. 2012 Oct;67(4):623-9. doi: 10.1016/j.jaad.2011.12.019. Epub 2012 Jan 20.

PMID:
22261417
20.

Low-dose rituximab is effective in pemphigus.

Horváth B, Huizinga J, Pas HH, Mulder AB, Jonkman MF.

Br J Dermatol. 2012 Feb;166(2):405-12. doi: 10.1111/j.1365-2133.2011.10663.x. Epub 2012 Jan 9.

PMID:
21967609

Supplemental Content

Support Center